In a retrospective analysis in lung adenocarcinomas, c-MYC copy number gain was an independent poor-prognostic factor for disease-free and overall survival, with a possible association with EGFR mutation status [40]. The gene discussed is EGFR; the disease is lung adenocarcinoma.